Company Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 11:39:00 2024-05-15 am EDT After market 02:18:10 pm
90.56 EUR -1.23% Intraday chart for Sanofi 90.66 +0.12%

Business Summary

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;

- consumer health products (12%).

At the end of 2023, the group had 54 production sites throughout the world.

Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).

Number of employees: 86,088

Sales per Business

EUR in Million2022Weight2023Weight Delta
Biopharma
88.0 %
30,688 71.4 % 37,890 88.0 % +23.47%
Consumer Healthcare
12.0 %
5,080 11.8 % 5,180 12.0 % +1.97%

Sales per region

EUR in Million2022Weight2023Weight Delta
United States
43.0 %
18,275 42.5 % 18,512 43.0 % +1.30%
Rest of the World
26.1 %
8,386 19.5 % 11,254 26.1 % +34.20%
Europe
18.6 %
7,703 17.9 % 8,013 18.6 % +4.02%
China
6.8 %
3,123 7.3 % 2,912 6.8 % -6.76%
France
5.5 %
2,296 5.3 % 2,379 5.5 % +3.61%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 19-08-31
Chief Operating Officer 40 21-12-31
Chief Tech/Sci/R&D Officer 51 -
Chief Tech/Sci/R&D Officer - 16-08-31
Chief Tech/Sci/R&D Officer 49 23-09-10
Chief Tech/Sci/R&D Officer - 18-12-31
Public Communications Contact - -
Corporate Officer/Principal - 20-11-30
- -
Corporate Officer/Principal 62 14-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 14-04-30
Director/Board Member 64 20-05-21
Chairman 60 22-09-01
Director/Board Member 52 20-04-27
Director/Board Member 66 22-05-02
Director/Board Member 53 22-05-02
Chief Executive Officer 56 19-08-31
Director/Board Member 64 22-05-02
Director/Board Member 58 21-04-30
Director/Board Member 56 21-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,264,799,969 1,102,027,070 ( 87.13 %) 13,450,388 ( 1.063 %) 87.13 %

Shareholders

NameEquities%Valuation
L'ORÉAL
9.348 %
118,227,307 9.348 % 11 767 M €
Amundi Asset Management SA (Investment Management)
2.427 %
30,690,674 2.427 % 3 055 M €
Dodge & Cox
1.780 %
22,512,304 1.780 % 2 241 M €
SANOFI
1.284 %
16,245,648 1.284 % 1 617 M €
Crédit Mutuel Asset Management SA
1.112 %
14,069,814 1.112 % 1 400 M €
Lyxor International Asset Management SAS
0.5764 %
7,289,777 0.5764 % 726 M €
Predica Prévoyance Dialogue du Crédit Agricole SA (Invt Port)
0.5390 %
6,817,764 0.5390 % 679 M €
Groupe des Assurances du Crédit Mutuel SA
0.5066 %
6,406,902 0.5066 % 638 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.4711 %
5,959,024 0.4711 % 593 M €
Fédéral Finance Gestion SA
0.4006 %
5,066,372 0.4006 % 504 M €
NameEquities%Valuation
Dodge & Cox
3.088 %
78,125,609 3.088 % 3 856 M €
Fidelity Management & Research Co. LLC
0.6748 %
17,069,956 0.6748 % 843 M €
Fisher Asset Management LLC
0.5514 %
13,947,583 0.5514 % 688 M €
Boston Partners Global Investors, Inc.
0.5165 %
13,066,403 0.5165 % 645 M €
Merrill Lynch International
0.4052 %
10,250,678 0.4052 % 506 M €
Eaton Vance Management
0.3111 %
7,868,480 0.3111 % 388 M €
BNY Mellon Investment Adviser, Inc.
0.2856 %
7,225,474 0.2856 % 357 M €
Invesco Advisers, Inc.
0.2741 %
6,934,477 0.2741 % 342 M €
BlackRock Investment Management LLC
0.2171 %
5,492,025 0.2171 % 271 M €
RBC Private Counsel (USA), Inc.
0.1985 %
5,020,229 0.1985 % 248 M €

Holdings

NameEquities%Valuation
16,245,648 1.28% 1,616,860,951 $
13,909,587 60.40% 1,387,703,578 $
EUROAPI
29.77%
28,298,074 29.77% 89,320,890 $
4,697,737 7.32% 22,126,341 $
1,919,455 7.30% 5,067,361 $
29,249 0.12% 517,280 $

Company contact information

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com
address Sanofi(SAN)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical Specialties
Pharmaceuticals: Major
Aventis, Inc.
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Biotechnology

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
91.69 EUR
Average target price
108.3 EUR
Spread / Average Target
+18.16%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW